DAILYGLIM M1

Description

DAILYGLIM M1 Tablet is a dual oral antidiabetic designed to control blood sugar in adults with type 2 diabetes who do not achieve adequate control with diet, exercise, or single-agent therapy alone.

Uses / Indications

• Type 2 diabetes mellitus: For adults to control blood glucose when monotherapy (either glimepiride or metformin alone) is insufficient.

• Reduces the risk of long-term complications of diabetes—kidney, nerve, eye, and cardiovascular issues—with regular and sustained blood sugar control.

How it Works / Key Benefits

• Glimepiride: Stimulates the pancreas to release more insulin, lowers blood sugar.

• Metformin (PR): Decreases liver glucose production, reduces intestinal glucose absorption, and improves insulin sensitivity throughout the body.

• The combination offers better blood sugar control than either medicine alone, with a lower risk of hypoglycemia than many traditional sulfonylureas.

Dosage & Administration

• Typically, one tablet once daily with breakfast or the first major meal.

• Swallow whole with water—do not break, crush, or chew.

• Do not skip meals and continue regular blood sugar monitoring.

• Never double the dose if a tablet is missed. Take the next dose at its regular time.

Safety & Side Effects

• Common: Low blood sugar (hypoglycemia—shakiness, sweating, confusion), nausea, headache, mild GI upset, taste change, modest weight gain.

• Rare/serious: Lactic acidosis (seek urgent care if rapid breathing, persistent vomiting), allergic reaction, anemia, liver dysfunction.

• Not suitable for type 1 diabetes, diabetic ketoacidosis, severe kidney/liver dysfunction, or during metabolic acidosis.

• Regular blood, kidney, and liver function monitoring is recommended during therapy.

• Alcohol increases the risk of hypoglycemia and should be avoided.

Note:
DAILYGLIM M1 is part of a long-term diabetes plan—continue healthy diet/exercise and follow your doctor’s instructions for best results and safety.